Shanghai Pharmaceutical Co Ltd (601607):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai Pharmaceutical Co Ltd (601607) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7471
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic anti-infection, and antineoplastic drug and immunomodulator. It also offers pharmaceuticals for diseases and disorders of cardiovascular system, digestive and metabolism, neurological system, musculoskeletal system, and respiratory system. The company also provides distribution and supply chain solutions to pharmaceutical manufacturers and dispensers; operates retail pharmacy stores; and provides consulting services, assets management and other services. Shanghai Pharma also provides traditional Chinese medicines. The company operates through a group of subsidiaries in China. Shanghai Pharma is headquartered in Shanghai, China.

Shanghai Pharmaceutical Co Ltd (601607) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shanghai Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Bracco Imaging Enters into Agreement with Shanghai Pharma 10
Shanghai Pharma Forms Joint Venture with DHL International 11
Shanghai Pharma Enters Into R&D Agreement With Second Military Medical University To Develop New Medicine And Medical Devices 12
Aerocrine Enters Into Distribution Agreement With Shanghai Pharma For Niox Mino And Test Kits 13
Equity Offering 14
Shanghai Pharma Raises USD400 Million in Private Placement of Shares 14
Acquisition 16
Shanghai Pharma to Acquire 26.34% Stake in Techpool Bio-Pharma from Takeda Pharma for USD143.4 Million 16
Shanghai Pharmaceutical Co Ltd – Key Competitors 17
Shanghai Pharmaceutical Co Ltd – Key Employees 18
Shanghai Pharmaceutical Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Affiliate 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Key Facts, 2017 2
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shanghai Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shanghai Pharmaceutical Co Ltd, Deals By Market, 2012 to YTD 2018 8
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bracco Imaging Enters into Agreement with Shanghai Pharma 10
Shanghai Pharma Forms Joint Venture with DHL International 11
Shanghai Pharma Enters Into R&D Agreement With Second Military Medical University To Develop New Medicine And Medical Devices 12
Aerocrine Enters Into Distribution Agreement With Shanghai Pharma For Niox Mino And Test Kits 13
Shanghai Pharma Raises USD400 Million in Private Placement of Shares 14
Shanghai Pharma to Acquire 26.34% Stake in Techpool Bio-Pharma from Takeda Pharma for USD143.4 Million 16
Shanghai Pharmaceutical Co Ltd, Key Competitors 17
Shanghai Pharmaceutical Co Ltd, Key Employees 18
Shanghai Pharmaceutical Co Ltd, Subsidiaries 19
Shanghai Pharmaceutical Co Ltd, Affiliate 21

List of Figures
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shanghai Pharmaceutical Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Shanghai Pharmaceutical Co Ltd (601607):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Aviva Ltd.:企業の戦略・SWOT・財務分析
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • VIA Technologies Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Monica Healthcare Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Monica Healthcare Ltd (MHL), a subsidiary of GE Healthcare LLC, is a medical device company that develops and commercializes fetal monitoring devices for use during labor and uterine activity applications. The company provides products such as monica AN24 with IF24, monica AN24 with VS progr …
  • Hindalco Industries Ltd:戦略・SWOT・企業財務分析
    Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Immuron Ltd (IMC)-製薬・医療分野:企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …
  • GlaxoSmithKline Plc (GSK):医療機器:M&Aディール及び事業提携情報
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervo …
  • Orion Diagnostica Oy:医療機器:M&Aディール及び事業提携情報
    Summary Orion Diagnostica Oy (Orion Diagnostica), a subsidiary of Orion Oyj, is a medical equipment company that develops, manufactures clinical diagnostic and hygiene monitoring tests. Its product portfolio provides diagnosis and treatment management kits, point of care systems, ready to use kits, …
  • Coloplast AS (COLO B):企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Henderson Land Development Co Ltd:企業の戦略・SWOT・財務情報
    Henderson Land Development Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Henderson Land Development Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Amryt Pharma plc (AMYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Amryt Pharma plc (Amryt) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include Lojuxta for the treatment of adult HoFH and Episalvan for the treatment of PTW. The …
  • Meiji Seika Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Meiji Seika Pharma Co Ltd (Meiji Seika Pharma), a subsidiary of Meiji Holdings Co Ltd, is a pharmaceutical solutions provider that carries out manufacturing and sale of ethical pharmaceuticals, agricultural chemicals and veterinary drugs. The company provides Streptomycin Meiji, Kanamycin Me …
  • Evonik Industries AG:企業の戦略・SWOT・財務情報
    Evonik Industries AG - Strategy, SWOT and Corporate Finance Report Summary Evonik Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Petronas Dagangan Berhad (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • Noble Mineral Exploration Inc (NOB):企業の財務・戦略的SWOT分析
    Summary Noble Mineral Exploration Inc (Noble Mineral) is a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration mining, production, and development of gold, nickel, copper, zinc, uranium, and mineral resources deposit prope …
  • Healthcare Locums Ltd:企業の戦略的SWOT分析
    Healthcare Locums Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hitachi High-Technologies Corp (8036):企業の財務・戦略的SWOT分析
    Hitachi High-Technologies Corp (8036) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆